Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 4

Conditions

Leukemia, Myeloid, Acute 9Myelodysplastic Syndromes 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Multiple Myeloma 4Myeloproliferative Disorders 2Lymphoma, Non-Hodgkin 2Hodgkin Disease 2Anemia, Refractory, with Excess of Blasts 2Recurrence 1Plasmablastic Lymphoma 1Neuroblastoma 1Neoplasms, Plasma Cell 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Leukemia, Plasma Cell 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Biphenotypic, Acute 1Immunoglobulin Light-chain Amyloidosis 1Hematologic Neoplasms 1HIV Infections 1Graft vs Host Disease 1Ganglioneuroblastoma 1Burkitt Lymphoma 1

Interventions

Dexamethasone 60Lenalidomide 33daratumumab 32pomalidomide 30Bortezomib 28carfilzomib 22Specimen Handling 21Biopsy 20Cyclophosphamide 19Magnetic Resonance Spectroscopy 16Calcium Dobesilate 16fludarabine 12isatuximab 11dexamethasone acetate 11dexamethasone 21-phosphate 11belantamab mafodotin 11auricularum 11talquetamab 9iberdomide 8tocilizumab 7selinexor 7elotuzumab 6trametinib 4pembrolizumab 4nirogacestat 4fludarabine phosphate 4X-Rays 4Sirolimus 4Melphalan 4sapanisertib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Multiple Myeloma × Melphalan × 30 days × Clear all
NCT01702831 2026-05-26

BuMelMCRN001

University Health Network, Toronto

Phase 2 Completed
78 enrolled
Plasma cell

Multiple Myeloma

NCT00734877 2026-05-22

TT4B

University of Arkansas

Phase 3 Active not recruiting
382 enrolled
Plasma cell

Multiple Myeloma

NCT00869232 2026-05-22

UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

University of Arkansas

Phase 2 Active not recruiting
90 enrolled
Plasma cell

Multiple Myeloma

NCT05231629 2026-05-13

MASTER-2

University of Alabama at Birmingham

Phase 2 Recruiting
300 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡